Ausgabe 5/2002
Inhalt (13 Artikel)
Opportunities for cardiovascular risk reduction with angiotensin II receptor blockers
Matthew R. Weir
Evolving strategies for the use of combination therapy in hypertension
Alan H. Gradman, Celso Acevedo
Hypertension as a cardiovascular risk factor in end-stage renal failure
Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers: Evidence for and against the combination in the treatment of hypertension and proteinuria
Niels Holmark Andersen, Carl Erik Mogensen